UiPath (PATH) CEO and Chairman Daniel Dines Sells $17M of Stock
Key Points
- UiPath CEO and Chairman Daniel Dines sold 1.25 million shares of PATH stock for roughly $16.8 million on October 15, 2026, cutting his stake about 4%.
- After the trade, Daniel Dines holds 30,241,238 $PATH shares, down 3.97% from before the trade.
- The software platform provider trades around $13.12, sitting below its 50-day moving average but above its 200-day mark ahead of December earnings.
- Wall Street firms including BMO Capital and Canaccord Genuity updated their targets in late September, reflecting a consensus hold rating.
Since the trade, $PATH is down 6.3% to date (from the $13.71 close on Oct 15, 2026).
Get UiPath text alerts
We text you when insiders, Congress, analysts or big funds move on $PATH.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated UiPath, Inc. alert may contain errors. Disclosures
UiPath, Inc. Chief Executive Officer and Chairman Daniel Dines sold 1.25 million shares of the automation software provider on October 15, 2026. According to a Form 4 filed with the SEC, the shares were disposed of at an average price of $13.44, totaling approximately $16.8 million. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
PATH
UiPath, Inc.
Inside Daniel Dines's PATH Trade
The planned sale reduced the executive's holdings by 3.97%, leaving him with 30,241,238 shares of UiPath following the transaction. The stock closed at $13.71 on the day of the sale. This follows recent insider sales by other company executives earlier in October, including transactions by the chief technology officer and chief legal officer.
Other Institutional Activity in UiPath
Large funds adjusted their positions in UiPath ahead of the filing. Tetragon Partners GP Ltd. grew its holdings by 5,742,312 shares, ending with 30,950,000 shares worth about $406.1 million. Two Sigma Investments, LP grew its holdings by 11,475,068 shares, ending with 15,034,443 shares worth about $197.3 million. Senvest Management LLC grew its holdings by 4,300,359 shares, ending with 12,085,222 shares worth about $158.6 million.
UiPath, Inc. Stock Up 0.5%
PATH recently traded around $13.12 as of October 19, 2026, down about 4.3% from its event-day close. The stock sits roughly 33.9% below its 52-week high of $19.84 and about 42.6% above its 52-week low of $9.20.
Recent Earnings
UiPath reported trailing twelve-month revenue of $1.72 billion alongside earnings of $0.67 per share. The company posted a net profit margin of 21.0% and a return on equity of 20.0%, with its next earnings report scheduled for December 2, 2026.
Dividend
UiPath does not pay a dividend to shareholders, keeping its payout ratio at zero.
Insider Buying and Selling at UiPath, Inc.
Prior insider transactions included Chief Technology Officer Malpani Raghavendra selling 29,564 shares on October 9, 2026, for roughly $399,265. Chief Legal and Admin Officer Brubaker Brad sold 27,404 shares on October 12, 2026, for about $373,555.
Analysts Set New Price Targets
On September 24, 2026, BMO Capital maintained its Market Perform rating while lowering its price target to $15.00 from $18.00. Canaccord Genuity maintained a Hold rating and dropped its target from $17.00 to $14.00 on the same day. TD Cowen maintained a Hold rating with a target lowered to $15.00 from $16.00. UBS kept a Neutral rating while adjusting its target to $14.00 on September 25, 2026. DA Davidson downgraded the stock to Underperform with a $10.00 target on September 28, 2026. The stock currently holds a consensus mean price target of $15.50 across 17 analyst opinions.
About UiPath, Inc.
Based in New York, UiPath provides an enterprise automation platform that combines robotic process automation with artificial intelligence tools. The software helps enterprise workers, bots, and AI agents collaborate smoothly across complex digital workflows.
Bottom Line
Investors will look toward UiPath's next earnings report on December 2, 2026, to gauge software demand and operational efficiency. The scheduled insider sale by the CEO reflects ongoing planned liquidity under established trading rules.
Related Filing Alerts
Source: Daniel Dines's Form 4 filing on $PATH (Oct 15, 2026). Written by software, not financial advice. How we make alerts